YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) Operating cash flow 2016–2025
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$842,802FY2025 · since FY2016: -$55,000 → -$842,802
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$842,802 | +37.0% |
| FY2024 | -$1.3M | -81.0% |
| FY2023 | -$738,971 | -23.0% |
| FY2022 | -$600,953 | +41.1% |
| FY2021 | -$1.0M | -1109.7% |
| FY2020 | $101,107 | +559.6% |
| FY2019 | -$22,000 | +31.3% |
| FY2018 | -$32,000 | +41.8% |
| FY2017 | -$55,000 | +0.0% |
| FY2016 | -$55,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More YBGJ financial trends
YBGJ RevenueYBGJ Net incomeYBGJ Net marginYBGJ Gross profitYBGJ Gross marginYBGJ Operating incomeYBGJ Operating marginYBGJ Free cash flowYBGJ Capital expendituresYBGJ Return on equityYBGJ Stock buybacksYBGJ Dividends paidYBGJ Total assetsYBGJ Total liabilitiesYBGJ Shareholders’ equityYBGJ overview →